-
-
-
-
-
-
-
SELLAS raises $31 million through warrant exercise by institutional investor
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Adds Two Hematology and Oncology Experts to Advisory Board
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Announces U.S. FDA Rare Pediatric Disease Designation Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
-
-
-
-
-
-
-
Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions
-
412,961 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

